Companies /Healthcare

Biogen Inc

NASDAQ: BIIB Drug Manufacturers - General
$249.65
▲ $5.60 (+2.29%) today
Markets closed · 6:54pm ET

BIIB Coverage Page 32

12:50pm ET
Health and Healthcare

ETF Folly: Biotech ETFs, Nothing but Confusion

Thinkstock24/7 Wall St. has always wondered about the confusing universe of biotech exchange-traded funds (ETFs). Biotech stocks can rise or fall regardless of the market direction, and the sector performed very well…

Jon C. Ogg
7:45am ET
Health and Healthcare

Biogen Idec Results Mixed

ThinkstockBiogen Idec Inc. (NASDAQ: BIIB) reported fourth-quarter and full-year 2012 results before markets opened this morning. For the quarter, the biotech firm posted adjusted diluted earnings per share (EPS) of $1.40 on…

Paul Ausick